IDERA_5C_RGB-01.jpg
Idera Pharmaceuticals Acquires Aceragen
28. September 2022 16:09 ET | Idera Pharmaceuticals, Inc.
Acquisition includes late-stage rare disease portfolio with anticipated 2023 clinical milestones and first potential product approval as early as late 2024 Conference call and webcast today at 5:00...